Read our Latest Press Release

Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by the mainstream in Europe and North America. Later, because people believed that its composition was unclear, quality control was difficult, and there were problems with abuse, it began to be gradually regulated and even banned. Since then, cannabis has become a plant that people are afraid

Improved bioavailability (faster onset, better efficacy) One of the biggest advantages of water-soluble THC is its greatly improved bioavailability. Bioavailability refers to the extent to which a substance reaches its intended site, often bypassing much of the digestive process.

Medical Atomization Technology + California-Based Manufacturing Breaks Trade Barriers and Reshapes the Industry Against the backdrop of escalating U.S.-China trade tensions, the vaping industry faces unprecedented tariff pressures. Traditional vaping brands, reliant on Chinese supply chains, have seen costs surge and market competitiveness plummet.